CG
CDMO

Colony Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Colony Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-91
Closed -$1K – 863
2013
Q4 		$1K Buy
+91
New +$856 ﹤0.01% 658

Other funds holding CDMO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Colony Group's CDMO Position: Q1 2014 in Review

Colony Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2014, closing a stake of 91 shares — an estimated $1K sold.

Colony Group first reported a position in CDMO in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 74 funds tracked by Wall St. Rank hold CDMO as of Q1 2014.

  • Colony Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Colony Group sold 91 Avid Bioservices, Inc. Common Stock shares in Q1 2014, an estimated $1K.
  • Colony Group first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Colony Group's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q4 2013.
  • 74 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2014.

Based on Colony Group's 13F filing for Q1 2014, filed 16 May 2014.